Aldeyra Therapeutics
ALDX
C$5.36
Share price
2.61%
Change (1 day)
20.70%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$40.4 Million
According to Aldeyra Therapeutics 's latest financial reports the company's total liabilities are C$40.4 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aldeyra Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$48.21 M | 27.41% |
| 2023-12-31 | C$37.84 M | -7.91% |
| 2022-12-31 | C$41.09 M | 17.67% |
| 2021-12-31 | C$34.92 M | 14.86% |
| 2020-12-31 | C$30.4 M | -15.15% |
| 2019-12-31 | C$35.83 M | 210.45% |
| 2018-12-31 | C$11.54 M | 100.71% |
| 2017-12-31 | C$5.75 M | 20.95% |
| 2016-12-31 | C$4.75 M | 3.03% |
| 2015-12-31 | C$4.61 M | 58.86% |
| 2014-12-31 | C$2.9 M | -51.68% |
| 2013-12-31 | C$6.01 M | -77.72% |
| 2012-12-31 | C$26.97 M | 922.71% |
| 2011-12-31 | C$2.63 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | C$11.13 B | 27,462.16% | 🇺🇸 USA |